Incorrect Timing of aPTT Monitoring
Introduction to aPTT Monitoring Guidelines
- The European Society of Cardiology explicitly states that the first aPTT should be measured 4 to 6 hours after initiation of the heparin infusion, not at 2 hours 1, 2
- The American College of Cardiology/American Heart Association guidelines specify that measurements should be made 6 hours after any dosage change and used to adjust UFH infusion until the aPTT exhibits a therapeutic level 3
Understanding the Impact of Incorrect Timing
- Drawing the aPTT at 2 hours does not allow sufficient time for the heparin infusion to reach steady-state pharmacokinetics, leading to a falsely subtherapeutic result 1, 2
- Premature aPTT testing at 2 hours will systematically underestimate the anticoagulant effect, leading to inappropriate dose escalation and potential over-anticoagulation 3
Clinical Pitfalls and Institutional Protocols
- Delays in laboratory turnaround time for aPTT results can be a source of variability in care, resulting in over- or under-anticoagulation for prolonged time periods, so institutions should establish protocols that account for both proper timing of draws AND rapid result reporting 3
- When 2 consecutive aPTT values are therapeutic, measurements may be made every 24 hours, but premature initial testing disrupts this entire monitoring cascade 3
- The American College of Cardiology/American Heart Association guidelines also imply that the nurse's adjustment based on a 2-hour aPTT likely led to unnecessary dose escalation, potentially increasing bleeding risk when the true steady-state level is reached 3